Wednesday, February 10, 2010, 3:59am EST - Canadian Markets open in 5 hours and 31 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

K V PHARMA CL B (KV-B)

On Feb 9: 3.10 USD   0.00 (0.00%)  
MORE ON KV-B
Quotes
Charts
News & Info
HereHeadlines
Company
Analyst Coverage
Ownership
Financials
Headlines Get Headlines for:
Mon, Jan 11, 2010
KV Pharmaceutical Amends Agreement to Secure Rights to Gestiva(TM)
PR Newswire (Mon, Jan 11)
Thu, Jan 7, 2010
KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes to Approve Appointment of Director
PR Newswire (Thu, Jan 7)
Tue, Dec 22, 2009
KV Pharmaceutical Receives Permission from NYSE for its Securities to Continue Trading on the NYSE until March 31, 2010
PR Newswire (Tue, Dec 22)
Tue, Dec 15, 2009
KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent
PR Newswire (Tue, Dec 15)
Wed, Dec 2, 2009
KV Pharmaceutical Enters Into Employment Agreement with Interim President and Chief Executive Officer David A. Van Vliet
PR Newswire (Wed, Dec 2)
Fri, Nov 13, 2009
KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes To Approve Bylaw Amendments
PR Newswire (Fri, Nov 13)
Wed, Mar 4, 2009
Mark & Associates, P.C. Encourages KV Pharmaceutical Shareholders to Explore Legal Rights -- KV-A, KV-B
GlobeNewswire (Wed, Mar 4)
Mark & Associates, P.C. Encourages KV Pharmaceutical Shareholders to Explore Legal Rights -- KV-A, KV-B
GlobeNewswire (Wed, Mar 4)
Thu, Jan 22, 2009
Brower Piven Announces Expanded Class Period and Encourages Investors Who Have Losses in Excess of $150,000 From Investment in KV Pharmaceutical Company to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit B
Marketwire (Thu, Jan 22)
Older Headlines
View headlines from:

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Headlines for Another Symbol:
Symbol Lookup
Latest News Canadian Indices